Abstract
Chronic GVHD, an autoimmune disease that follows allogeneic hematopoietic-cell transplantation, is characterized by infections and debilitating tissue injury leading to irreversible fibrosis. Insights into the pathophysiology of the disease are providing new therapeutic targets.
Original language | English (US) |
---|---|
Pages (from-to) | 2565-2579 |
Number of pages | 15 |
Journal | New England Journal of Medicine |
Volume | 377 |
Issue number | 26 |
DOIs | |
State | Published - Dec 28 2017 |
Bibliographical note
Publisher Copyright:© 2017 Massachusetts Medical Society.